ARCA:PBE

Invesco Biotechnology & Genome ETF

$ 64.2961 -1.3221 ( -2.01%) 03:59 PM EST
PE Ratio:
40.85
PB Ratio:
3.5
Volume:
2.92K
Dividend Yield %:
0.36
Last Holding update 2025-06-29 30 Stocks (2 new)
Value $221.00 Mil Turnover 12 %
Top Holdings: NTRA(5.18%) GILD(5.11%) NBIX(4.97%) AMGN(4.93%) TGTX(4.55%)
Portfolio Report
Registrant: Invesco Biotechnology & Genome ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Invesco Biotechnology & Genome ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Invesco Biotechnology & Genome ETF Key Statistics

Name Value
Day's Open ($) 65.67
Day's Range ($) 64.2961 - 65.73
Day's Volume 2,919
52-Week Range ($) 54.52 - 72.84
Beta 0.82
3-Year Sharpe Ratio 0.05
3-Year Sortino Ratio 0.07
Volatility 14.66
14-Day RSI 46.91
14-Day ATR ($) 1.0162
20-Day SMA ($) 65.083

Fundamental Data

Name Value
Market Cap (Mil $) 223.107
Shares Outstanding (Mil) 3.47
PE Ratio 40.85
PE Ratio (10y Range) 14.2 - 40.85
PE Ratio (10y Median) 21.74
PB Ratio 3.5
PB Ratio (10y Range) 2.94 - 5.95
PB Ratio (10y Median) 4.15

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.23
Dividend Yield % 0.36
Dividend Yield % (10y Range) 0.01 - 1.84
Dividend Yield % (10y Median) 0.1
Next Dividend Payment Date
Dividend Frequency Quarterly

PBE Invesco Biotechnology & Genome ETF Fundamental Charts

Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF

Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF

Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF

Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PBE

No Available Data

ARCA:PBE is held by these investors

No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2025-04-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
NTRA
Natera Inc
75,925
11,459.4
-2.27%
5.180
-0.12%
0.060
-6.20%
-12.26%
18,966.3
Medical Diagnostics & Research
GILD
Gilead Sciences Inc
106,203
11,314.9
-24.75%
5.110
-1.33%
0.010
+4.26%
+18.82%
134,618.0
Drug Manufacturers
NBIX
Neurocrine Biosciences Inc
102,195
11,005.4
+86.46%
4.970
+2.30%
0.100
+30.22%
-3.28%
13,065.5
Drug Manufacturers
AMGN
Amgen Inc
37,524
10,916.5
-13.62%
4.930
-0.66%
0.010
+7.24%
+15.01%
158,494.3
Drug Manufacturers
TGTX
TG Therapeutics Inc
221,180
10,065.9
+9.88%
4.550
+0.41%
0.140
-1.07%
+25.95%
6,018.4
Biotechnology
UTHR
United Therapeutics Corp
33,135
10,042.9
-4.36%
4.540
-0.21%
0.070
+2.56%
-17.24%
13,171.6
Drug Manufacturers
BIIB
Biogen Inc
82,559
9,996.2
+2.59%
4.520
+0.11%
0.060
+5.38%
-18.26%
18,314.5
Drug Manufacturers
REGN
Regeneron Pharmaceuticals Inc
16,373
9,803.5
-3.92%
4.430
-0.18%
0.020
-3.52%
-23.63%
58,573.4
Biotechnology
ILMN
Illumina Inc
123,695
9,598.7
+39.29%
4.340
+1.22%
0.080
+35.03%
-28.06%
15,219.0
Medical Diagnostics & Research
PTGX
Protagonist Therapeutics Inc
184,113
8,436.1
+20.33%
3.810
+0.64%
0.300
+19.88%
+43.73%
3,438.8
Biotechnology

Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns

Invesco Biotechnology & Genome ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
AXSM
Axsome Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.98%
●
95.65 ($116.78) 137.75
$111.70
-4.35%
Sold Out
0
-71,451
PTCT
PTC Therapeutics Inc
2025-04-30
New Buy
New Buy
+2.89%
●
39.77 ($50.25) 57.17
$47.63
-5.21%
New holding
128,294
128,294
SRPT
Sarepta Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.71%
●
49.3 ($84.38) 119.02
$14.07
-83.32%
Sold Out
0
-60,764
DVAX
Dynavax Technologies Corp
2025-04-30
New Buy
New Buy
+2.55%
●
10.31 ($12.81) 14.4
$10.72
-16.32%
New holding
481,349
481,349
INCY
Incyte Corp
2025-04-30
Reduce
Reduce
-2.53%
●
55.17 ($65.35) 75.26
$67.86
3.84%
Reduce -50.07%
86,742
-86,977
NBIX
Neurocrine Biosciences Inc
2025-04-30
Add
Add
+2.30%
●
87.54 ($112.46) 152.42
$132.02
17.39%
Add 86.46%
102,195
47,388
GILD
Gilead Sciences Inc
2025-04-30
Reduce
Reduce
-1.33%
●
95.48 ($107.46) 117.41
$108.22
0.71%
Reduce -24.75%
106,203
-34,937
ILMN
Illumina Inc
2025-04-30
Add
Add
+1.22%
●
70.3 ($88.29) 132.74
$96.14
8.89%
Add 39.29%
123,695
34,890
XNCR
Xencor Inc
2025-04-30
Add
Add
+0.89%
●
7.67 ($12.87) 18.28
$8.97
-30.30%
Add 67.09%
446,673
179,350
RPRX
Royalty Pharma PLC
2025-04-30
Reduce
Reduce
-0.89%
●
30.85 ($32.44) 33.86
$35.59
9.71%
Reduce -27.2%
191,591
-71,592

Invesco Biotechnology & Genome ETF Total Holding History ($B)

To

Invesco Biotechnology & Genome ETF's Asset Allocation

To

Invesco Biotechnology & Genome ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2025-04-30

Invesco Biotechnology & Genome ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Invesco Biotechnology & Genome ETF's Holdings Heat Map

Size field:

Invesco Biotechnology & Genome ETF's Holdings Bubble Chart

Invesco Biotechnology & Genome ETF News

  • 1

Discussions on Invesco Biotechnology & Genome ETF

User's Avatar
How would you rate this stock? PBE
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.